Kiora Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Kiora Pharmaceuticals

25/03/2024 13:32

* Kiora Pharmaceuticals Inc  KPRX.OQ  reported a quarterly
adjusted loss of 47 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of $-1.76.  The mean expectation of
three analysts for the quarter was for a loss of 42 cents per
share. Wall Street expected results to range from -48 cents
to -36 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Kiora Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 47 cents​.
    * The company reported a quarterly loss of $2.27 million.
    * Kiora Pharmaceuticals Inc shares had risen by 14.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 99.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is  "buy."

Wall Street's median 12-month price target for Kiora
Pharmaceuticals Inc is $3.00 
This summary was machine generated from LSEG data March 25 at
01:32 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.42          -0.47          Missed
 Sep. 30 2023      -0.35          -0.89          Missed
 Jun. 30 2023      -1.07          -0.79          Beat
 Mar. 31 2023      -1.68          -1.00          Beat